Divi's Laboratories Reports Strong Profit Growth in Q4 2023

Divi's Laboratories, a leading pharmaceutical company in the largecap industry, has recently announced its financial results for the quarter ending December 2023. The company's stock has been given a 'Hold' call by MarketsMOJO. According to the financial report, Divi's Lab. has shown a flat performance in the quarter, with a slight improvement in its score from -11 to -3 in the last three months. However, there are some positive aspects to the company's financials. One of the highlights of the quarter is the Profit After Tax (PAT) which stands at Rs 358.00 crore, the highest in the last five quarters. This shows a positive trend in the near term for the company's profitability. Additionally, the Earnings per Share (EPS) for the quarter is also at its highest in the last five quarters, at Rs 13.51. This indicates that the company has been able to generate higher earnings for its shareholders. Overall, Divi's Laboratories has shown a stable financial performance in the quarter ending December 2023. While the stock has been given a 'Hold' call by MarketsMOJO, investors can keep an eye on the company's future financial reports to make informed decisions.